EW

Eli Wallace

Chief Scientific Officer, Residence for Oncology at Navire Pharma

No bio yet


Org chart

No direct reports

Teams


Offices

This person is not in any offices


Navire Pharma

Navire Pharma is developing SHP2 inhibitors as effective additions to the therapeutic arsenal for difficult-to-treat cancers.